Maxi use for micro mixer
A recently-introduced microstructured mixer that can provide much tighter heat and reaction control compared to conventional systems was showcased at the ACHEMASIA meeting last week.
Archives for May 17, 2004
Another enzyme target in Alzheimer's
The enzyme alpha secretase could join its beta and gamma cousins as a promising new target for Alzheimer's disease drugs, if research conducted in Germany is borne out in additional study.
Euro biotechs link up on cancer vaccines
A new generation of potent, targetted vaccines for cancer could be the offspring of a marriage between two technologies developed at European biotechnology companies Avidex and Active Biotech.
UCB makes friendly offer for Celltech
Belgian chemicals and pharmaceuticals company UCB has made an offer to buy UK biotechnology firm Celltech for £1.53 billion (€2.25bn) in a move seen as a way of getting hold of the latter's much-touted arthritis drug.
Biotech opens door to affordable treatment
New biotechnology processes are poised to change the economics of manufacturing drugs, creating the potential for delivering both affordable medicines to patients in the developing world and laying the foundation for new markets.